Effects persist only during treatment
Meta-analysis of results reported from SURPASS-1 to -5 clinical trials regarding achievement of HbA 1c targets
Loureiro D, Tout I, Narguet S, Bed CM, Roinard M, Sleiman A, Boyer N, Pons-Kerjean N, Castelnau C, Giuly N, Tonui D, Soumelis V, El Benna J, Soussan P, Moreau R, Paradis V, Mansouri A, Asselah T
"The use of semaglutide medicines and risk of non-arteritic anterior ischemic optic neuropathy (NAION)"
Salas-Salvad, J
Overnight-fasted participants consumed 75 g glucose as control or 75 g glucose plus 24 g inulin, or 28.2 g resistant starch, and blood was collected at intervals over 6 h